(668106, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668107, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668108, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668109, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668110, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668111, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668112, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668113, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668114, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668115, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668116, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668117, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668118, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668119, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668120, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668121, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668122, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668123, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668124, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668125, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668126, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668127, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668128, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668129, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668130, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668131, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668132, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668133, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668134, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668135, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668136, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668137, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668138, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668139, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668140, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668141, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668142, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668143, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668144, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668145, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668146, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668147, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668148, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668149, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668150, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668151, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668152, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668153, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668154, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668155, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668156, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668157, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668158, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668159, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668160, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668161, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668162, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668163, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668164, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668165, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668166, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668167, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668168, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668169, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668170, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668171, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668172, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668173, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668174, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668175, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668176, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668177, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668178, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668179, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668180, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668181, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668182, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668183, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668184, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668185, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668186, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668187, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668188, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668189, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668190, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668191, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668192, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668193, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668194, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668195, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668196, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668197, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668198, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668199, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668200, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668201, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668202, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668203, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668204, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668205, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668206, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668207, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668208, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668209, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668210, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668211, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668212, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668213, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668214, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668215, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668216, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668217, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668218, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668219, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668220, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668221, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668222, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668223, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668224, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668225, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668226, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668227, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668228, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668229, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668230, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668231, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668232, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668233, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668234, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668235, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668236, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668237, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668238, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668239, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668240, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668241, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668242, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668243, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668244, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668245, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668246, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668247, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668248, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668249, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668250, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668251, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668252, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668253, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668254, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668255, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668256, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668257, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668258, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668259, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668260, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668261, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668262, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668263, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668264, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668265, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668266, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668267, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668268, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668269, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668270, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668271, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668272, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668273, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668274, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668275, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668276, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668277, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668278, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668279, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668280, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668281, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668282, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668283, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668284, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668285, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668286, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668287, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668288, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668289, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668290, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668291, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668292, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668293, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668294, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668295, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668296, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668297, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668298, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668299, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668300, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668301, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668302, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668303, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668304, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668305, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668306, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668307, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668308, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668309, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668310, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668311, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668312, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668313, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668314, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668315, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668316, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668317, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668318, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668319, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668320, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668321, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668322, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668323, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668324, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668325, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668326, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668327, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668328, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668329, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668330, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668331, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668332, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668333, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668334, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668335, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668336, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668337, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668338, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668339, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668340, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668341, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668342, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668343, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668344, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668345, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668346, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668347, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668348, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668349, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668350, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668351, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668352, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668353, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668354, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668355, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668356, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668357, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668358, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668359, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668360, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668361, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668362, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668363, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668364, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668365, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668366, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668367, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668368, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668369, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668370, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668371, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668372, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668373, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668374, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668375, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668376, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668377, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668378, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668379, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668380, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668381, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668382, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668383, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668384, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668385, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668386, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668387, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668388, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668389, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668390, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668391, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668392, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668393, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668394, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668395, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668396, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668397, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668398, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668399, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668400, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668401, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668402, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668403, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668404, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668405, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668406, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668407, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668408, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668409, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668410, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668411, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668412, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668413, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668414, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668415, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668416, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668417, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668418, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668419, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668420, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668421, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668422, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668423, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668424, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668425, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668426, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668427, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668428, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668429, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668430, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668431, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668432, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668433, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668434, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668435, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668436, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668437, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668438, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668439, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668440, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668441, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668442, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668443, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668444, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668445, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668446, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668447, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668448, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668449, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668450, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668451, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668452, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668453, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668454, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668455, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668456, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668457, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668458, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668459, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668460, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668461, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668462, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668463, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668464, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668465, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668466, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668467, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668468, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668469, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668470, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668471, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668472, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668473, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668474, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668475, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668476, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668477, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668478, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668479, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668480, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668481, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668482, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668483, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668484, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668485, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668486, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668487, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668488, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668489, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668490, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668491, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668492, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668493, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668494, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668495, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668496, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668497, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668498, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668499, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668500, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668501, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668502, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668503, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668504, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668505, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668506, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668507, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668508, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668509, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668510, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668511, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668512, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668513, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668514, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668515, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668516, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668517, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668518, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668519, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668520, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668521, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668522, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668523, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668524, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668525, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668526, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668527, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668528, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668529, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668530, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668531, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668532, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668533, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668534, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668535, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668536, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668537, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668538, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668539, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668540, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668541, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668542, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668543, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668544, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668545, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668546, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668547, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668548, 'HP:0011246', 'Underdeveloped superior crus of antihelix', 'MP:0000053', 'excessive ear growth', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(668549, 'HP:0011246', 'Underdeveloped superior crus of antihelix', 'MP:0006290', 'proboscis', 0.43478260869565216, 6.5236679405794336, 1.684154792609432, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(668550, 'HP:0011246', 'Underdeveloped superior crus of antihelix', 'MP:0000017', 'big ears', 0.42, 10.255471829629862, 2.0754031339584467, 'UPHENO:0086699', 'abnormal external ear morphology'),
(668551, 'HP:0011246', 'Underdeveloped superior crus of antihelix', 'MP:0030071', 'abnormal face shape', 0.40816326530612246, 6.5236679405794336, 1.6317847923055813, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(668552, 'HP:0011246', 'Underdeveloped superior crus of antihelix', 'MP:0009578', 'otocephaly', 0.43478260869565216, 6.5236679405794336, 1.684154792609432, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(668553, 'HP:0011246', 'Underdeveloped superior crus of antihelix', 'MP:0000022', 'abnormal ear shape', 0.5434782608695652, 11.115294171581601, 2.457828461350544, 'UPHENO:0005986', 'abnormal shape of external ear'),
(668554, 'HP:0011246', 'Underdeveloped superior crus of antihelix', 'MP:0000018', 'small ears', 0.42, 10.255471829629862, 2.0754031339584467, 'UPHENO:0086699', 'abnormal external ear morphology'),
(668555, 'HP:0011246', 'Underdeveloped superior crus of antihelix', 'MP:0011495', 'abnormal head shape', 0.4444444444444444, 6.5236679405794336, 1.7027648027813058, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(668556, 'HP:0011246', 'Underdeveloped superior crus of antihelix', 'MP:0003736', 'folded helix', 0.43859649122807015, 11.115294171581601, 2.20796943425934, 'UPHENO:0005986', 'abnormal shape of external ear'),
(668557, 'HP:0011246', 'Underdeveloped superior crus of antihelix', 'MP:0003735', 'cup-shaped ears', 0.4807692307692308, 11.115294171581601, 2.3116858412520074, 'UPHENO:0005986', 'abnormal shape of external ear'),
(668558, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003480', 'increased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668559, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668560, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668561, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0000948', 'nonconvulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668562, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0006060', 'increased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668563, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668564, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0000921', 'demyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668565, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0006080', 'brain ischemia', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668566, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003477', 'abnormal nerve fiber response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668567, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668568, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0021001', 'impaired neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668569, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668570, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668571, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668572, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003217', 'increased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668573, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668574, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003475', 'increased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668575, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668576, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002578', 'impaired ability to fire action potentials', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668577, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668578, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003471', 'abnormal summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668579, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668580, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003466', 'decreased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668581, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668582, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0004513', 'avnosmia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668583, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668584, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0004558', 'delayed allantois development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668585, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003880', 'abnormal central pattern generator function', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668586, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668587, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003473', 'decreased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668588, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668589, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0004994', 'abnormal brain wave pattern', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668590, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0010050', 'hypermyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668591, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0021010', 'impaired synaptic physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668592, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003481', 'decreased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668593, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668594, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002634', 'abnormal sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668595, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003482', 'increased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668596, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001919', 'abnormal reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668597, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668598, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003476', 'decreased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668599, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668600, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003216', 'absence seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668601, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668602, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0011397', 'endoneurial edema', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668603, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668604, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001533', 'abnormal skeleton physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668605, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002106', 'abnormal muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668606, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0012685', 'abnormal primitive streak elongation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668607, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668608, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001984', 'abnormal olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668609, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003635', 'abnormal synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668610, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668611, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668612, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668613, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668614, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003474', 'abnormal summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668615, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003486', 'abnormal channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668616, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003468', 'increased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668617, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001912', 'increased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668618, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003483', 'decreased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668619, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0014255', 'increased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668620, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0020424', 'increased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668621, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003990', 'decreased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668622, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668623, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668624, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668625, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668626, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668627, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001752', 'abnormal hypothalamus secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668628, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668629, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668630, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002064', 'seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668631, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668632, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668633, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668634, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668635, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003485', 'abnormal channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668636, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003469', 'decreased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668637, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0014253', 'decreased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668638, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668639, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0004835', 'abnormal miniature endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668640, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0031092', 'dysgeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668641, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0013438', 'dysmyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668642, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668643, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0004768', 'abnormal axonal transport', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668644, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668645, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001900', 'impaired synaptic plasticity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668646, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668647, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0008921', 'increased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668648, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0008814', 'decreased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668649, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668650, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668651, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668652, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001496', 'audiogenic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668653, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668654, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0012006', 'abnormal hippocampus physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668655, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668656, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003633', 'abnormal nervous system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668657, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668658, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0006082', 'CNS inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668659, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0004811', 'abnormal neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668660, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002195', 'psychomotor seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668661, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668662, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0006058', 'decreased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668663, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668664, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0014252', 'abnormal paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668665, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0004859', 'abnormal synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668666, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0012011', 'febrile seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668667, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668668, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003996', 'clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668669, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668670, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0005666', 'abnormal adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668671, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668672, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668673, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668674, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668675, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003472', 'increased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668676, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0000947', 'convulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668677, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003470', 'abnormal summary potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668678, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0005403', 'abnormal nerve conduction', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668679, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668680, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0000920', 'abnormal myelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668681, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668682, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001986', 'abnormal taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668683, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668684, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668685, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668686, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002207', 'abnormal long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668687, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002826', 'tonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668688, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668689, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668690, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001500', 'decreased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668691, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668692, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668693, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003889', 'enhanced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668694, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668695, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001663', 'abnormal digestive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668696, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002915', 'abnormal synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668697, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003484', 'abnormal channel response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668698, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0013806', 'encephalopathy', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668699, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003997', 'tonic-clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668700, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668701, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0011994', 'increased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668702, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003464', 'abnormal single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668703, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002635', 'reduced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668704, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003219', 'increased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668705, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668706, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668707, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668708, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0021009', 'abnormal synaptic physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668709, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003467', 'abnormal single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668710, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668711, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0000951', 'sporadic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668712, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001499', 'abnormal kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668713, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668714, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003088', 'abnormal prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668715, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001790', 'abnormal immune system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668716, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668717, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003463', 'abnormal single cell response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668718, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668719, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668720, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668721, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0030990', 'nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668722, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0014254', 'increased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668723, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668724, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668725, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668726, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0009358', 'environmentally induced seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668727, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0005402', 'abnormal action potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668728, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0014120', 'focal seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668729, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668730, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668731, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0008840', 'abnormal spike wave discharge', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668732, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668733, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0021015', 'increased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668734, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668735, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0003465', 'increased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668736, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002914', 'abnormal endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668737, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668738, 'HP:0032696', 'Focal cognitive seizure with receptive dysphasia/aphasia', 'MP:0002193', 'minimal clonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(668739, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030726', 'abnormal circulating valine level', 0.423728813559322, 9.920646740728058, 2.0502838518580435, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668740, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030708', 'abnormal circulating glutamine level', 0.43103448275862066, 9.920646740728058, 2.0678831776772872, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668741, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030660', 'abnormal circulating arginine level', 0.43103448275862066, 9.920646740728058, 2.0678831776772872, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668742, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0001569', 'abnormal circulating bilirubin level', 0.4074074074074074, 8.79336607669424, 1.892744693742462, 'UPHENO:0081550', 'abnormal acid bodily fluid level'),
(668743, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030717', 'abnormal circulating lysine level', 0.43103448275862066, 9.920646740728058, 2.0678831776772872, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668744, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030654', 'abnormal circulating glycine level', 0.423728813559322, 9.920646740728058, 2.0502838518580435, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668745, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030652', 'abnormal circulating glutathione level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668746, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0010063', 'abnormal circulating creatine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668747, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030686', 'abnormal circulating cystathionine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668748, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0011651', 'abnormal circulating histidine level', 0.43859649122807015, 9.920646740728058, 2.0859436356710397, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668749, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0003977', 'abnormal circulating carnitine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668750, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030637', 'abnormal circulating taurine level', 0.43103448275862066, 9.920646740728058, 2.0678831776772872, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668751, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030680', 'abnormal circulating hydroxyproline level', 0.4098360655737705, 9.920646740728058, 2.016392528295827, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668752, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030749', 'abnormal circulating leucine level', 0.423728813559322, 9.920646740728058, 2.0502838518580435, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668753, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0005328', 'abnormal circulating creatinine level', 0.44642857142857145, 9.920646740728058, 2.104485721526934, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668754, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0006076', 'abnormal circulating homocysteine level', 0.43103448275862066, 9.920646740728058, 2.0678831776772872, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668755, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030669', 'abnormal circulating phenylalanine level', 0.423728813559322, 9.920646740728058, 2.0502838518580435, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668756, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030666', 'abnormal circulating proline level', 0.43103448275862066, 9.920646740728058, 2.0678831776772872, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668757, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030626', 'decreased circulating cysteine level', 0.44642857142857145, 9.920646740728058, 2.104485721526934, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668758, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0020835', 'abnormal circulating citrulline level', 0.43103448275862066, 9.920646740728058, 2.0678831776772872, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668759, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030714', 'abnormal circulating isoleucine level', 0.423728813559322, 9.920646740728058, 2.0502838518580435, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668760, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030625', 'increased circulating cysteine level', 0.44642857142857145, 9.920646740728058, 2.104485721526934, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668761, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0005311', 'abnormal circulating amino acid level', 0.4807692307692308, 9.920646740728058, 2.183928044206838, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668762, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030745', 'increased circulating homocitrulline level', 0.46296296296296297, 9.920646740728058, 2.143103359522429, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668763, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030643', 'abnormal circulating methionine level', 0.43103448275862066, 9.920646740728058, 2.0678831776772872, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668764, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.4716981132075472, 9.920646740728058, 2.1632268372503214, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668765, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030624', 'abnormal circulating cysteine level', 0.46296296296296297, 9.920646740728058, 2.143103359522429, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668766, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030693', 'abnormal circulating serine level', 0.43103448275862066, 9.920646740728058, 2.0678831776772872, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668767, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0013722', 'abnormal circulating tyrosine level', 0.43859649122807015, 9.920646740728058, 2.0859436356710397, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668768, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030649', 'abnormal circulating ornithine level', 0.4166666666666667, 9.920646740728058, 2.0331263631748744, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668769, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030672', 'abnormal circulating alanine level', 0.44642857142857145, 9.920646740728058, 2.104485721526934, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668770, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030738', 'abnormal circulating glutamic acid level', 0.43103448275862066, 9.920646740728058, 2.0678831776772872, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668771, 'HP:0033157', 'Elevated circulating 3-methylhistidine concentration', 'MP:0030702', 'abnormal circulating threonine level', 0.43103448275862066, 9.920646740728058, 2.0678831776772872, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(668772, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0011432', 'decreased urine flow rate', 0.4666666666666667, 8.666588959537362, 2.011071401297685, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668773, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0008055', 'increased urine osmolality', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668774, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0001985', 'abnormal gustatory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668775, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0009643', 'abnormal urine homeostasis', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668776, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668777, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0006273', 'abnormal urine organic cation level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668778, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0003621', 'dysuria', 0.4666666666666667, 8.666588959537362, 2.011071401297685, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668779, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0013284', 'abnormal renal glomerular filtration', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668780, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0011900', 'podocyturia', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668781, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0001948', 'vesicoureteral reflux', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668782, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668783, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0031483', 'decreased urine hypoxanthine level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668784, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0030619', 'homogentisic aciduria', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668785, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0011295', 'abnormal tubuloglomerular feedback response', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668786, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0031481', 'decreased urine xanthine level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668787, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0031480', 'abnormal urine xanthine level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668788, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0011923', 'abnormal bladder urine volume', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668789, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0011418', 'leukocyturia', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668790, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0009348', 'abnormal urine pH', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668791, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0001761', 'abnormal urination pattern', 0.4666666666666667, 8.666588959537362, 2.011071401297685, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668792, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0003280', 'urinary incontinence', 0.4666666666666667, 8.666588959537362, 2.011071401297685, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668793, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0002164', 'abnormal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668794, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668795, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0011758', 'renal ischemia', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668796, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0001756', 'abnormal urination', 0.4827586206896552, 8.666588959537362, 2.045451180593282, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668797, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0011444', 'abnormal renal water homeostasis', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668798, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0013285', 'abnormal renal filtration', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668799, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0004050', 'abnormal renal sympathetic nerve activity', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668800, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0031404', 'increased tubuloglomerular feedback response', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668801, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0031484', 'increased urine hypoxanthine level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668802, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0010680', 'abnormal skin adnexa physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668803, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0002136', 'abnormal kidney physiology', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668804, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668805, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0011297', 'absent tubuloglomerular feedback response', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668806, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668807, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0009645', 'crystalluria', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668808, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0010386', 'abnormal urinary bladder physiology', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668809, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0000327', 'hemosiderinuria', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668810, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0011417', 'abnormal renal transport', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668811, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0010028', 'aciduria', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668812, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0013305', 'isosthenuria', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668813, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.5, 8.666588959537362, 2.081656667120849, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668814, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0011466', 'increased urine urea nitrogen level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668815, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0011421', 'cylindruria', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668816, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0011431', 'increased urine flow rate', 0.4666666666666667, 8.666588959537362, 2.011071401297685, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668817, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0011420', 'pyuria', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668818, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0004051', 'increased renal sympathetic nerve activity', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668819, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0001983', 'abnormal olfactory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668820, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0011442', 'abnormal renal sodium ion transport', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668821, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0031479', 'increased urine xanthine level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668822, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0009349', 'increased urine pH', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668823, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0003589', 'abnormal ureter physiology', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668824, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0010107', 'abnormal renal reabsorption', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668825, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0011467', 'decreased urine urea nitrogen level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668826, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0014037', 'stranguria', 0.4666666666666667, 8.666588959537362, 2.011071401297685, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668827, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0002988', 'decreased urine osmolality', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668828, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0009350', 'decreased urine pH', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668829, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0002893', 'ketoaciduria', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668830, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0002987', 'abnormal urine osmolality', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668831, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0004052', 'decreased renal sympathetic nerve activity', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668832, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0001760', 'abnormal urine enzyme level', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668833, 'HP:0020130', 'Increased urinary neutrophil gelatinase-associated lipocalin', 'MP:0011296', 'decreased tubuloglomerular feedback response', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(668834, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011012', 'bronchiectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668835, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668836, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005190', 'osteomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668837, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668838, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668839, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668840, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668841, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001837', 'defective assembly of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668842, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668843, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005402', 'abnormal action potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668844, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668845, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668846, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668847, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668848, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668849, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002635', 'reduced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668850, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002473', 'impaired complement classical pathway', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668851, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668852, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668853, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011763', 'urethritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668854, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020155', 'enhanced humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668855, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668856, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668857, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668858, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668859, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668860, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668861, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668862, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008748', 'abnormal central T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668863, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668864, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668865, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002933', 'joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668866, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668867, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668868, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668869, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668870, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668871, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668872, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668873, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668874, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001841', 'decreased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668875, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001846', 'increased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668876, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0021015', 'increased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668877, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001835', 'abnormal antigen presentation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668878, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668879, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668880, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0013942', 'enthesitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668881, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668882, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668883, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668884, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003762', 'abnormal immune organ physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668885, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668886, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005025', 'abnormal response to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668887, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668888, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668889, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003470', 'abnormal summary potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668890, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668891, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0013971', 'blood in lymph vessels', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668892, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668893, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668894, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668895, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668896, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008694', 'decreased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668897, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668898, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668899, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002472', 'impaired complement alternative pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668900, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020371', 'abnormal glymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668901, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008696', 'increased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668902, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668903, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668904, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008663', 'increased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668905, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002406', 'increased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668906, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0030153', 'dental pulp inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668907, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668908, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668909, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668910, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668911, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008711', 'increased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668912, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668913, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668914, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668915, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0000427', 'abnormal hair cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668916, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668917, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008566', 'increased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668918, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668919, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012553', 'decreased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668920, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0021016', 'decreased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668921, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003303', 'peritoneal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668922, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0006138', 'congestive heart failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668923, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668924, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012554', 'increased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668925, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668926, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668927, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668928, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668929, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668930, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008675', 'increased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668931, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668932, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668933, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668934, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668935, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668936, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668937, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001194', 'dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668938, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668939, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668940, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668941, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668942, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003725', 'increased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668943, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668944, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668945, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668946, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668947, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668948, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668949, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668950, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668951, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668952, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668953, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668954, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668955, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668956, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011717', 'increased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668957, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011925', 'abnormal heart echocardiography feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668958, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668959, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668960, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668961, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668962, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668963, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668964, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668965, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668966, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668967, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668968, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668969, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668970, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668971, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668972, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668973, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031066', 'cytokine storm', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668974, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668975, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668976, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668977, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668978, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668979, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0009062', 'impaired lectin complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668980, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002499', 'chronic inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668981, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001845', 'abnormal inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668982, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668983, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008751', 'abnormal interleukin level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668984, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010538', 'increased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668985, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668986, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001793', 'abnormal susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668987, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004510', 'myositis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668988, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668989, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668990, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668991, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668992, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668993, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668994, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020001', 'decreased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668995, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003777', 'lip inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668996, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668997, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031111', 'meningoencephalitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668998, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668999, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669000, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669001, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005403', 'abnormal nerve conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669002, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008744', 'abnormal B cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669003, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669004, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008660', 'increased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669005, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031053', 'pleuritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669006, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669007, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669008, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669009, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669010, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008669', 'increased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669011, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001844', 'autoimmune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669012, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669013, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669014, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001872', 'sinus inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669015, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669016, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669017, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001864', 'vascular inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669018, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669019, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669020, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001861', 'lung inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669021, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669022, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669023, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669024, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031054', 'bronchiolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669025, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669026, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669027, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669028, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008699', 'increased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669029, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003875', 'abnormal hair follicle regression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669030, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669031, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669032, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0009057', 'increased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669033, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669034, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669035, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669036, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669037, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001839', 'abnormal level of surface class I molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669038, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669039, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001862', 'interstitial pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669040, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001627', 'abnormal cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669041, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669042, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005363', 'decreased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669043, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669044, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005671', 'abnormal response to transplant', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669045, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669046, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005399', 'increased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669047, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669048, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002418', 'increased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669049, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031240', 'abnormal CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669050, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669051, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669052, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669053, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669054, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669055, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031222', 'decreased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669056, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020096', 'high mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669057, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001849', 'ear inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669058, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669059, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669060, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669061, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669062, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669063, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669064, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669065, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669066, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003746', 'stomatitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669067, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008564', 'increased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669068, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008721', 'abnormal chemokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669069, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669070, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005532', 'abnormal vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669071, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669072, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669073, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669074, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669075, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0030132', 'periodontium inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669076, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669077, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669078, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669079, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669080, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669081, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020000', 'abnormal response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669082, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002471', 'abnormal complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669083, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669084, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669085, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669086, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669087, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669088, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003726', 'decreased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669089, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669090, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0030129', 'tongue inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669091, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008555', 'abnormal interferon secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669092, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011764', 'ureteritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669093, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669094, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005087', 'decreased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669095, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669096, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003278', 'esophageal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669097, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669098, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669099, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669100, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669101, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008737', 'abnormal spleen physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669102, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005005', 'abnormal self tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669103, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669104, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669105, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001636', 'irregular heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669106, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669107, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669108, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669109, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669110, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669111, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669112, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003412', 'abnormal afterhyperpolarization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669113, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669114, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008690', 'increased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669115, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669116, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002500', 'granulomatous inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669117, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669118, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669119, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669120, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669121, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669122, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669123, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0006080', 'brain ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669124, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669125, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669126, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669127, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669128, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669129, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669130, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669131, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669132, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669133, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669134, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005044', 'sepsis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669135, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669136, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001800', 'abnormal humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669137, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669138, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669139, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669140, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669141, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0030990', 'nerve inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669142, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008568', 'abnormal interleukin secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669143, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008672', 'increased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669144, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669145, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669146, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669147, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001867', 'rhinitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669148, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669149, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669150, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669151, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008687', 'increased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669152, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005001', 'abnormal clonal deletion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669153, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669154, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005088', 'increased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669155, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010922', 'alveolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669156, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031125', 'aspiration pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669157, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008705', 'increased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669158, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669159, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669160, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669161, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002409', 'decreased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669162, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669163, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669164, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669165, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669166, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008666', 'increased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669167, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669168, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012565', 'perivasculitis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669169, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008750', 'abnormal interferon level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669170, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004947', 'skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669171, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669172, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669173, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031095', 'pharyngitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669174, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669175, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669176, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669177, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669178, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669179, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669180, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669181, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669182, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669183, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008684', 'increased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669184, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003659', 'abnormal lymph circulation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669185, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669186, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031128', 'cardiovascular shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669187, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002419', 'abnormal innate immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669188, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669189, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669190, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001840', 'increased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669191, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669192, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669193, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669194, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669195, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0013498', 'trachea inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669196, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669197, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669198, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669199, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004829', 'increased anti-chromatin antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669200, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669201, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001790', 'abnormal immune system physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669202, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005000', 'abnormal immune tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669203, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669204, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669205, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020142', 'increased anti-sperm antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669206, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669207, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003633', 'abnormal nervous system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669208, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669209, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669210, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001819', 'abnormal immune cell physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669211, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669212, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669213, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031110', 'meningitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669214, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011399', 'increased endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669215, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669216, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031170', 'abnormal vasculature physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669217, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003477', 'abnormal nerve fiber response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669218, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669219, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0006082', 'CNS inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669220, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003767', 'palate inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669221, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669222, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669223, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669224, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669225, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669226, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669227, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669228, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669229, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669230, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003880', 'abnormal central pattern generator function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669231, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669232, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008667', 'decreased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669233, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669234, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669235, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008708', 'increased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669236, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008678', 'increased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669237, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669238, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008747', 'abnormal T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669239, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004072', 'abnormal frontal plane axis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669240, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669241, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669242, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008713', 'abnormal cytokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669243, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669244, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669245, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669246, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669247, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002420', 'abnormal adaptive immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669248, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669249, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669250, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669251, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011566', 'abnormal complement protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669252, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669253, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005364', 'increased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669254, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031223', 'increased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669255, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010539', 'decreased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669256, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004796', 'increased anti-histone antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669257, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669258, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003889', 'enhanced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669259, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669260, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031055', 'bronchitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669261, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020002', 'increased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669262, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008722', 'abnormal chemokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669263, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669264, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005043', 'defective assembly of class II molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669265, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669266, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020381', 'muscle gating pore current', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669267, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669268, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669269, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669270, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002405', 'respiratory system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669271, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669272, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669273, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008702', 'increased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669274, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669275, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010211', 'abnormal acute phase protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669276, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669277, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003865', 'lymph node inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669278, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669279, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669280, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669281, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010559', 'heart block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669282, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669283, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669284, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669285, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669286, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669287, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669288, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669289, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669290, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012006', 'abnormal hippocampus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669291, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020097', 'low mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669292, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669293, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669294, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669295, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669296, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669297, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669298, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669299, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003009', 'abnormal cytokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669300, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669301, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669302, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669303, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669304, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669305, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669306, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020386', 'adipose tissue inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669307, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669308, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669309, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669310, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669311, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005042', 'abnormal level of surface class II molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669312, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011926', 'abnormal heart valve physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669313, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669314, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669315, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001876', 'decreased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669316, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0014048', 'abnormal Peyers patch physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669317, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669318, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004994', 'abnormal brain wave pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669319, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669320, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020154', 'impaired humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669321, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011762', 'renal/urinary system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669322, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669323, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669324, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669325, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669326, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669327, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669328, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669329, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669330, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001629', 'abnormal heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669331, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669332, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001866', 'nasal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669333, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669334, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002634', 'abnormal sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669335, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669336, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669337, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669338, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669339, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001873', 'stomach inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669340, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008562', 'increased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669341, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002498', 'abnormal acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669342, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669343, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669344, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008693', 'increased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669345, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004751', 'increased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669346, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669347, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669348, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669349, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669350, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004752', 'decreased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669351, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669352, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669353, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669354, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669355, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008681', 'increased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669356, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001869', 'pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669357, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669358, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669359, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669360, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669361, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008651', 'increased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669362, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669363, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669364, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669365, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669366, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002410', 'decreased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669367, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669368, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669369, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669370, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669371, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669372, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669373, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669374, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669375, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669376, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0008565', 'decreased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669377, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002254', 'reproductive system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669378, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669379, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669380, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669381, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669382, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669383, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0030130', 'gum inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669384, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669385, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669386, 'HP:0034176', 'Abnormal circulating interleukin 17A concentration', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669387, 'HP:0008664', 'Urethral sphincter sclerosis', 'MP:0000537', 'abnormal urethra morphology', 0.41379310344827586, 11.297292005324488, 2.1621150569395273, 'UPHENO:0002790', 'abnormal urethra'),
(669388, 'HP:0001345', 'Psychotic mentation', 'MP:0003477', 'abnormal nerve fiber response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669389, 'HP:0001345', 'Psychotic mentation', 'MP:0000948', 'nonconvulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669390, 'HP:0001345', 'Psychotic mentation', 'MP:0003889', 'enhanced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669391, 'HP:0001345', 'Psychotic mentation', 'MP:0004994', 'abnormal brain wave pattern', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669392, 'HP:0001345', 'Psychotic mentation', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669393, 'HP:0001345', 'Psychotic mentation', 'MP:0003469', 'decreased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669394, 'HP:0001345', 'Psychotic mentation', 'MP:0003465', 'increased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669395, 'HP:0001345', 'Psychotic mentation', 'MP:0021009', 'abnormal synaptic physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669396, 'HP:0001345', 'Psychotic mentation', 'MP:0011994', 'increased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669397, 'HP:0001345', 'Psychotic mentation', 'MP:0005645', 'abnormal hypothalamus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669398, 'HP:0001345', 'Psychotic mentation', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669399, 'HP:0001345', 'Psychotic mentation', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669400, 'HP:0001345', 'Psychotic mentation', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669401, 'HP:0001345', 'Psychotic mentation', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669402, 'HP:0001345', 'Psychotic mentation', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669403, 'HP:0001345', 'Psychotic mentation', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669404, 'HP:0001345', 'Psychotic mentation', 'MP:0003463', 'abnormal single cell response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669405, 'HP:0001345', 'Psychotic mentation', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669406, 'HP:0001345', 'Psychotic mentation', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669407, 'HP:0001345', 'Psychotic mentation', 'MP:0000947', 'convulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669408, 'HP:0001345', 'Psychotic mentation', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669409, 'HP:0001345', 'Psychotic mentation', 'MP:0014120', 'focal seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669410, 'HP:0001345', 'Psychotic mentation', 'MP:0002635', 'reduced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669411, 'HP:0001345', 'Psychotic mentation', 'MP:0003475', 'increased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669412, 'HP:0001345', 'Psychotic mentation', 'MP:0012011', 'febrile seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669413, 'HP:0001345', 'Psychotic mentation', 'MP:0003474', 'abnormal summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669414, 'HP:0001345', 'Psychotic mentation', 'MP:0003482', 'increased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669415, 'HP:0001345', 'Psychotic mentation', 'MP:0002634', 'abnormal sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669416, 'HP:0001345', 'Psychotic mentation', 'MP:0003880', 'abnormal central pattern generator function', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669417, 'HP:0001345', 'Psychotic mentation', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669418, 'HP:0001345', 'Psychotic mentation', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669419, 'HP:0001345', 'Psychotic mentation', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669420, 'HP:0001345', 'Psychotic mentation', 'MP:0005403', 'abnormal nerve conduction', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669421, 'HP:0001345', 'Psychotic mentation', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669422, 'HP:0001345', 'Psychotic mentation', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669423, 'HP:0001345', 'Psychotic mentation', 'MP:0003476', 'decreased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669424, 'HP:0001345', 'Psychotic mentation', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669425, 'HP:0001345', 'Psychotic mentation', 'MP:0002064', 'seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669426, 'HP:0001345', 'Psychotic mentation', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669427, 'HP:0001345', 'Psychotic mentation', 'MP:0003472', 'increased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669428, 'HP:0001345', 'Psychotic mentation', 'MP:0003464', 'abnormal single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669429, 'HP:0001345', 'Psychotic mentation', 'MP:0002578', 'impaired ability to fire action potentials', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669430, 'HP:0001345', 'Psychotic mentation', 'MP:0008814', 'decreased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669431, 'HP:0001345', 'Psychotic mentation', 'MP:0000951', 'sporadic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669432, 'HP:0001345', 'Psychotic mentation', 'MP:0021015', 'increased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669433, 'HP:0001345', 'Psychotic mentation', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669434, 'HP:0001345', 'Psychotic mentation', 'MP:0003633', 'abnormal nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669435, 'HP:0001345', 'Psychotic mentation', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669436, 'HP:0001345', 'Psychotic mentation', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669437, 'HP:0001345', 'Psychotic mentation', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669438, 'HP:0001345', 'Psychotic mentation', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669439, 'HP:0001345', 'Psychotic mentation', 'MP:0003471', 'abnormal summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669440, 'HP:0001345', 'Psychotic mentation', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669441, 'HP:0001345', 'Psychotic mentation', 'MP:0013806', 'encephalopathy', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669442, 'HP:0001345', 'Psychotic mentation', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669443, 'HP:0001345', 'Psychotic mentation', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669444, 'HP:0001345', 'Psychotic mentation', 'MP:0003470', 'abnormal summary potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669445, 'HP:0001345', 'Psychotic mentation', 'MP:0003468', 'increased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669446, 'HP:0001345', 'Psychotic mentation', 'MP:0003466', 'decreased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669447, 'HP:0001345', 'Psychotic mentation', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669448, 'HP:0001345', 'Psychotic mentation', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669449, 'HP:0001345', 'Psychotic mentation', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669450, 'HP:0001345', 'Psychotic mentation', 'MP:0003473', 'decreased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669451, 'HP:0001345', 'Psychotic mentation', 'MP:0012006', 'abnormal hippocampus physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669452, 'HP:0001345', 'Psychotic mentation', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669453, 'HP:0001345', 'Psychotic mentation', 'MP:0006080', 'brain ischemia', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669454, 'HP:0001345', 'Psychotic mentation', 'MP:0005402', 'abnormal action potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669455, 'HP:0001345', 'Psychotic mentation', 'MP:0003480', 'increased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669456, 'HP:0001345', 'Psychotic mentation', 'MP:0003467', 'abnormal single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669457, 'HP:0003986', 'Exostoses of the radius', 'MP:0000552', 'abnormal radius morphology', 0.43859649122807015, 11.180882513209177, 2.214474167635927, 'UPHENO:0087510', 'abnormal radius bone morphology'),
(669458, 'HP:0003986', 'Exostoses of the radius', 'MP:0005108', 'abnormal ulna morphology', 0.41379310344827586, 10.120647406075808, 2.0464247113113765, 'UPHENO:0087349', 'abnormal forelimb zeugopod morphology'),
(669459, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0009347', 'increased trabecular bone thickness', 0.41304347826086957, 9.62605573046134, 1.9939858426886405, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(669460, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0009715', 'thick epidermis stratum basale', 0.5116279069767442, 9.62605573046134, 2.219224807408531, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(669461, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0009601', 'epidermis stratum granulosum hyperplasia', 0.4318181818181818, 7.4735768925632104, 1.7964482696212054, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(669462, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0009474', 'thick epidermis stratum spinosum', 0.5116279069767442, 9.62605573046134, 2.219224807408531, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(669463, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0010690', 'thick hair follicle outer root sheath', 0.43137254901960786, 9.62605573046134, 2.0377478247943026, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(669464, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0009612', 'thick epidermis suprabasal layer', 0.5116279069767442, 9.62605573046134, 2.219224807408531, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(669465, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0009599', 'thick epidermis stratum granulosum', 0.5116279069767442, 9.62605573046134, 2.219224807408531, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(669466, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0010929', 'increased osteoid thickness', 0.41304347826086957, 9.62605573046134, 1.9939858426886405, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(669467, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0009600', 'hypergranulosis', 0.5, 9.62605573046134, 2.1938614052010372, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(669468, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0001200', 'thick skin', 0.55, 9.62605573046134, 2.3009412534338503, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(669469, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0001244', 'thin dermal layer', 0.4090909090909091, 8.594057268470833, 1.875033519897196, 'UPHENO:0085691', 'abnormal anatomical entity thickness'),
(669470, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0010692', 'thick hair follicle inner root sheath', 0.43137254901960786, 9.62605573046134, 2.0377478247943026, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(669471, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0000588', 'thick tail', 0.48717948717948717, 9.62605573046134, 2.1655523300828636, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(669472, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0001199', 'thin skin', 0.4186046511627907, 8.594057268470833, 1.8967109281441068, 'UPHENO:0085691', 'abnormal anatomical entity thickness'),
(669473, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0010973', 'increased periosteum thickness', 0.4418604651162791, 9.62605573046134, 2.0623708353002064, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(669474, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0002953', 'thick ventricular wall', 0.41304347826086957, 9.62605573046134, 1.9939858426886405, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(669475, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0031094', 'organomegaly', 0.43243243243243246, 5.9605885577567275, 1.6054755709009296, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(669476, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0001874', 'acanthosis', 0.4222222222222222, 7.4735768925632104, 1.776375591908054, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(669477, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0030584', 'skin atrophy', 0.40476190476190477, 7.4735768925632104, 1.7392582379906794, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(669478, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0009611', 'epidermis stratum spinosum hyperplasia', 0.4318181818181818, 7.4735768925632104, 1.7964482696212054, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(669479, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0004971', 'dermal hyperplasia', 0.4523809523809524, 7.4735768925632104, 1.8387234246482052, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(669480, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0001245', 'thick dermal layer', 0.5365853658536586, 9.62605573046134, 2.272707776168618, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(669481, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0001222', 'epidermal hyperplasia', 0.4418604651162791, 7.4735768925632104, 1.817217147682207, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(669482, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0011190', 'thick embryonic epiblast', 0.4222222222222222, 9.62605573046134, 2.0160195043080176, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(669483, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0004148', 'increased compact bone thickness', 0.40425531914893614, 9.62605573046134, 1.9726591777251068, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(669484, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0001214', 'skin hyperplasia', 0.4523809523809524, 7.4735768925632104, 1.8387234246482052, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(669485, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0000381', 'enlarged hair follicles', 0.40425531914893614, 7.4735768925632104, 1.7381695003328228, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(669486, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0013328', 'visceromegaly', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(669487, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0004127', 'thick hypodermis', 0.4878048780487805, 9.62605573046134, 2.166941840864322, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(669488, 'HP:0007431', 'Congenital ichthyosiform erythroderma', 'MP:0001219', 'thick epidermis', 0.5238095238095238, 9.62605573046134, 2.245488737076384, 'UPHENO:0048320', 'increased thickness of the anatomical entity in independent continuant'),
(669489, 'HP:0031231', 'Narrow incisura width', 'MP:0000022', 'abnormal ear shape', 0.5434782608695652, 11.115294171581601, 2.457828461350544, 'UPHENO:0005986', 'abnormal shape of external ear'),
(669490, 'HP:0031231', 'Narrow incisura width', 'MP:0003735', 'cup-shaped ears', 0.5098039215686274, 12.607147267911277, 2.5351869984232676, 'UPHENO:0083647', 'abnormal helix of outer ear morphology'),
(669491, 'HP:0031231', 'Narrow incisura width', 'MP:0000053', 'excessive ear growth', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(669492, 'HP:0031231', 'Narrow incisura width', 'MP:0009578', 'otocephaly', 0.43478260869565216, 6.5236679405794336, 1.684154792609432, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(669493, 'HP:0031231', 'Narrow incisura width', 'MP:0006290', 'proboscis', 0.43478260869565216, 6.5236679405794336, 1.684154792609432, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(669494, 'HP:0031231', 'Narrow incisura width', 'MP:0000017', 'big ears', 0.42, 10.255471829629862, 2.0754031339584467, 'UPHENO:0086699', 'abnormal external ear morphology'),
(669495, 'HP:0031231', 'Narrow incisura width', 'MP:0003736', 'folded helix', 0.4642857142857143, 12.607147267911277, 2.419363216713724, 'UPHENO:0083647', 'abnormal helix of outer ear morphology'),
(669496, 'HP:0031231', 'Narrow incisura width', 'MP:0030092', 'abnormal outer ear helix morphology', 0.41304347826086957, 12.607147267911277, 2.2819509106212372, 'UPHENO:0083647', 'abnormal helix of outer ear morphology'),
(669497, 'HP:0031231', 'Narrow incisura width', 'MP:0011495', 'abnormal head shape', 0.4444444444444444, 6.5236679405794336, 1.7027648027813058, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(669498, 'HP:0031231', 'Narrow incisura width', 'MP:0030071', 'abnormal face shape', 0.40816326530612246, 6.5236679405794336, 1.6317847923055813, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(669499, 'HP:0031231', 'Narrow incisura width', 'MP:0000018', 'small ears', 0.42, 10.255471829629862, 2.0754031339584467, 'UPHENO:0086699', 'abnormal external ear morphology'),
(669500, 'HP:4000092', 'Poor conversational reciprocity', 'MP:0003633', 'abnormal nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669501, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0010545', 'abnormal heart layer morphology', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(669502, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0010478', 'intracranial aneurysm', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(669503, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0010435', 'abnormal heart atrium and ventricle connection', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(669504, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0000288', 'abnormal pericardium morphology', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(669505, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0005406', 'abnormal heart size', 0.41935483870967744, 7.506484928906078, 1.774226810934282, 'UPHENO:0076810', 'abnormal heart morphology'),
(669506, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0003228', 'abnormal sinus venosus morphology', 0.41935483870967744, 7.506484928906078, 1.774226810934282, 'UPHENO:0076810', 'abnormal heart morphology'),
(669507, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0002839', 'increased susceptibility to dystrophic cardiac calcinosis', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(669508, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0010426', 'abnormal heart and great artery attachment', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(669509, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0010427', 'double outlet left ventricle', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(669510, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0000650', 'mesocardia', 0.41935483870967744, 7.506484928906078, 1.774226810934282, 'UPHENO:0076810', 'abnormal heart morphology'),
(669511, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0003141', 'cardiac fibrosis', 0.41935483870967744, 7.506484928906078, 1.774226810934282, 'UPHENO:0076810', 'abnormal heart morphology'),
(669512, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0000292', 'distended pericardium', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(669513, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0006113', 'abnormal heart septum morphology', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(669514, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0012688', 'abnormal heart ventricles weight', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(669515, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0000285', 'abnormal heart valve morphology', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(669516, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0002837', 'dystrophic cardiac calcinosis', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(669517, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0006065', 'abnormal heart position or orientation', 0.43333333333333335, 7.506484928906078, 1.8035548607844731, 'UPHENO:0076810', 'abnormal heart morphology'),
(669518, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.44, 5.978701727774094, 1.6219213175183935, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(669519, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0031274', 'increased susceptibility to induced aneurysm formation', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(669520, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0000266', 'abnormal heart morphology', 0.46153846153846156, 7.506484928906078, 1.8613252014758086, 'UPHENO:0076810', 'abnormal heart morphology'),
(669521, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0010409', 'cor triatriatum', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(669522, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0003105', 'abnormal heart atrium morphology', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(669523, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0013332', 'peliosis', 0.4230769230769231, 5.978701727774094, 1.5904247014496937, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(669524, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0010434', 'double inlet heart right ventricle', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(669525, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0005608', 'cardiac interstitial fibrosis', 0.40625, 7.506484928906078, 1.7462844849474253, 'UPHENO:0076810', 'abnormal heart morphology'),
(669526, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0004110', 'transposition of great arteries', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(669527, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0012515', 'abnormal heart apex morphology', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(669528, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0010425', 'abnormal heart and great vessel attachment', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(669529, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0011648', 'thick heart valve cusps', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(669530, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0000267', 'abnormal heart development', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(669531, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0012082', 'delayed heart development', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(669532, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0010433', 'double inlet heart left ventricle', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(669533, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0010442', 'partial anomalous pulmonary venous connection', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(669534, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4230769230769231, 5.978701727774094, 1.5904247014496937, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(669535, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0002925', 'abnormal cardiovascular development', 0.4230769230769231, 5.978701727774094, 1.5904247014496937, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(669536, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0005294', 'abnormal heart ventricle morphology', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(669537, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0006126', 'abnormal cardiac outflow tract development', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(669538, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0000644', 'dextrocardia', 0.41935483870967744, 7.506484928906078, 1.774226810934282, 'UPHENO:0076810', 'abnormal heart morphology'),
(669539, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0010551', 'abnormal coronary vessel morphology', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(669540, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(669541, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0010224', 'abnormal heart ventricle outflow tract morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(669542, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0003279', 'aneurysm', 0.4230769230769231, 5.978701727774094, 1.5904247014496937, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(669543, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0012500', 'abnormal angioblastic cord morphology', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(669544, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0010441', 'total anomalous pulmonary venous connection', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(669545, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0002838', 'decreased susceptibility to dystrophic cardiac calcinosis', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(669546, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0000284', 'double outlet right ventricle', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(669547, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0012700', 'abnormal endocardial heart tube morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(669548, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0011660', 'ectopia cordis', 0.41935483870967744, 7.506484928906078, 1.774226810934282, 'UPHENO:0076810', 'abnormal heart morphology'),
(669549, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0004032', 'abnormal interventricular groove morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(669550, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0010440', 'anomalous pulmonary venous connection', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(669551, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0012687', 'abnormal heart atrium weight', 0.41935483870967744, 7.506484928906078, 1.774226810934282, 'UPHENO:0076810', 'abnormal heart morphology'),
(669552, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0011510', 'biventricular, discordant atrioventricular connection', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(669553, 'HP:0011547', 'Absent left sided atrioventricular connection', 'MP:0011511', 'biventricular, ambiguous atrioventricular connection', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(669554, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003889', 'enhanced sensorimotor gating', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669555, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669556, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003477', 'abnormal nerve fiber response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669557, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0009358', 'environmentally induced seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669558, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669559, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0004859', 'abnormal synaptic plasticity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669560, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003216', 'absence seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669561, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003480', 'increased nerve fiber response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669562, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669563, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0013806', 'encephalopathy', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669564, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669565, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0004513', 'avnosmia', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669566, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0010680', 'abnormal skin adnexa physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669567, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669568, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003484', 'abnormal channel response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669569, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0002826', 'tonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669570, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669571, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669572, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0001983', 'abnormal olfactory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669573, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003475', 'increased summary potential intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669574, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0002193', 'minimal clonic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669575, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669576, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003482', 'increased nerve fiber response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669577, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0000947', 'convulsive seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669578, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669579, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669580, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003996', 'clonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669581, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669582, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669583, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669584, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669585, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669586, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669587, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669588, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669589, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003464', 'abnormal single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669590, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669591, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0006058', 'decreased cerebral infarct size', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669592, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669593, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669594, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003473', 'decreased summary potential threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669595, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0000951', 'sporadic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669596, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0013438', 'dysmyelination', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669597, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003476', 'decreased summary potential intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669598, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669599, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0000920', 'abnormal myelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669600, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669601, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003472', 'increased summary potential threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669602, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0005403', 'abnormal nerve conduction', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669603, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669604, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0005645', 'abnormal hypothalamus physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669605, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0002634', 'abnormal sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669606, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669607, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669608, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0004994', 'abnormal brain wave pattern', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669609, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669610, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0010050', 'hypermyelination', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669611, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0021010', 'impaired synaptic physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669612, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0001499', 'abnormal kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669613, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669614, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669615, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0004811', 'abnormal neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669616, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0001985', 'abnormal gustatory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669617, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669618, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669619, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669620, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669621, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003470', 'abnormal summary potential', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669622, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669623, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669624, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669625, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003467', 'abnormal single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669626, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003880', 'abnormal central pattern generator function', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669627, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0008840', 'abnormal spike wave discharge', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669628, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0011994', 'increased nerve conduction velocity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669629, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669630, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003465', 'increased single cell response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669631, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003633', 'abnormal nervous system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669632, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669633, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669634, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0002578', 'impaired ability to fire action potentials', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669635, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0002195', 'psychomotor seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669636, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669637, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0012006', 'abnormal hippocampus physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669638, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003468', 'increased single cell response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669639, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0021009', 'abnormal synaptic physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669640, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0011397', 'endoneurial edema', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669641, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669642, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0005402', 'abnormal action potential', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669643, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669644, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0000948', 'nonconvulsive seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669645, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0002635', 'reduced sensorimotor gating', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669646, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0000921', 'demyelination', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669647, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669648, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669649, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003469', 'decreased single cell response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669650, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0012011', 'febrile seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669651, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003463', 'abnormal single cell response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669652, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003635', 'abnormal synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669653, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003466', 'decreased single cell response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669654, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003471', 'abnormal summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669655, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0008814', 'decreased nerve conduction velocity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669656, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669657, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0002164', 'abnormal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669658, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003474', 'abnormal summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669659, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0006080', 'brain ischemia', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669660, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669661, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003997', 'tonic-clonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669662, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0002064', 'seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669663, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669664, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0014120', 'focal seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669665, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0006060', 'increased cerebral infarct size', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669666, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669667, 'HP:0032832', 'Neonatal bilateral asymmetric myoclonic seizure', 'MP:0021015', 'increased tau protein phosphorylation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669668, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0003470', 'abnormal summary potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669669, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669670, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669671, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0006080', 'brain ischemia', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669672, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669673, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.42857142857142855, 7.291997705654976, 1.7678070804960966, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669674, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0012006', 'abnormal hippocampus physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669675, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0003880', 'abnormal central pattern generator function', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669676, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669677, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.42857142857142855, 7.291997705654976, 1.7678070804960966, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669678, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669679, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0003477', 'abnormal nerve fiber response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669680, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0002635', 'reduced sensorimotor gating', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669681, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669682, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0003633', 'abnormal nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669683, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669684, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0004513', 'avnosmia', 0.4166666666666667, 7.291997705654976, 1.7430812882238855, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669685, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0004994', 'abnormal brain wave pattern', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669686, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669687, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.40540540540540543, 7.291997705654976, 1.7193647914495462, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669688, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0021015', 'increased tau protein phosphorylation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669689, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669690, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0003889', 'enhanced sensorimotor gating', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669691, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669692, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0005402', 'abnormal action potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669693, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669694, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669695, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.40540540540540543, 7.291997705654976, 1.7193647914495462, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669696, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0003463', 'abnormal single cell response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669697, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669698, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0013806', 'encephalopathy', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669699, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0002634', 'abnormal sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669700, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669701, 'HP:0003431', 'Decreased motor nerve conduction velocity', 'MP:0005403', 'abnormal nerve conduction', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(669702, 'HP:0007643', 'Peripheral tractional retinal detachment', 'MP:0003099', 'retina detachment', 0.417910447761194, 11.562753148552822, 2.198225499275237, 'UPHENO:0081667', 'detached anatomical entity from anatomical entity'),
(669703, 'HP:0007643', 'Peripheral tractional retinal detachment', 'MP:0020443', 'tractional retina detachment', 0.4117647058823529, 11.562753148552822, 2.1820022111363917, 'UPHENO:0081667', 'detached anatomical entity from anatomical entity'),
(669704, 'HP:0007643', 'Peripheral tractional retinal detachment', 'MP:0006186', 'retina fibrosis', 0.4090909090909091, 9.356059413574362, 1.9563943495644465, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(669705, 'HP:0007643', 'Peripheral tractional retinal detachment', 'MP:0020442', 'serous retina detachment', 0.4117647058823529, 11.562753148552822, 2.1820022111363917, 'UPHENO:0081667', 'detached anatomical entity from anatomical entity'),
(669706, 'HP:0007643', 'Peripheral tractional retinal detachment', 'MP:0001326', 'retina degeneration', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(669707, 'HP:0007643', 'Peripheral tractional retinal detachment', 'MP:0020441', 'rhegmatogenous retina detachment', 0.4117647058823529, 11.562753148552822, 2.1820022111363917, 'UPHENO:0081667', 'detached anatomical entity from anatomical entity'),
(669708, 'HP:0007643', 'Peripheral tractional retinal detachment', 'MP:0006188', 'calcified retina', 0.4057971014492754, 9.356059413574362, 1.9485024482960456, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(669709, 'HP:0003059', 'Abnormality of the radioulnar joints', 'MP:0003854', 'abnormal forelimb stylopod morphology', 0.4375, 7.310231061031986, 1.788358490124811, 'UPHENO:0002880', 'abnormal arm'),
(669710, 'HP:0003059', 'Abnormality of the radioulnar joints', 'MP:0003855', 'abnormal forelimb zeugopod morphology', 0.5, 10.120647406075808, 2.2495163264661815, 'UPHENO:0087349', 'abnormal forelimb zeugopod morphology'),
(669711, 'HP:0003059', 'Abnormality of the radioulnar joints', 'MP:0002109', 'abnormal limb morphology', 0.42857142857142855, 5.844765229200882, 1.5826873929943446, 'UPHENO:0086635', 'abnormal limb morphology'),
(669712, 'HP:0003059', 'Abnormality of the radioulnar joints', 'MP:0006279', 'abnormal limb development', 0.41379310344827586, 5.844765229200882, 1.5551602949913577, 'UPHENO:0086635', 'abnormal limb morphology'),
(669713, 'HP:0003059', 'Abnormality of the radioulnar joints', 'MP:0013133', 'pale limbs', 0.41379310344827586, 5.844765229200882, 1.5551602949913577, 'UPHENO:0086635', 'abnormal limb morphology'),
(669714, 'HP:0003059', 'Abnormality of the radioulnar joints', 'MP:0000550', 'abnormal forelimb morphology', 0.4482758620689655, 6.940627358012219, 1.763892205383417, 'UPHENO:0086633', 'abnormal forelimb morphology'),
(669715, 'HP:0410345', 'Increased urinary polyhexose', 'MP:0011473', 'increased urine glycosaminoglycan level', 0.41509433962264153, 9.50911518495075, 1.9867510886099355, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(669716, 'HP:0410345', 'Increased urinary polyhexose', 'MP:0030612', 'organic aciduria', 0.46808510638297873, 9.50911518495075, 2.109757140752383, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(669717, 'HP:0410345', 'Increased urinary polyhexose', 'MP:0001759', 'increased urine glucose level', 0.4107142857142857, 10.668547812575419, 2.09325703019257, 'UPHENO:0052116', 'abnormal independent continuant carbohydrate level'),
(669718, 'HP:0003113', 'Hypochloremia', 'MP:0005566', 'decreased blood urea nitrogen level', 0.4107142857142857, 9.791230332350247, 2.0053424077237483, 'UPHENO:0079822', 'decreased role blood level'),
(669719, 'HP:0003113', 'Hypochloremia', 'MP:0003018', 'abnormal circulating chloride level', 0.46, 15.192109768632433, 2.6435526273503465, 'UPHENO:0051596', 'abnormal blood chloride level'),
(669720, 'HP:0003113', 'Hypochloremia', 'MP:0005560', 'decreased circulating glucose level', 0.40350877192982454, 9.791230332350247, 1.9876738482680443, 'UPHENO:0079822', 'decreased role blood level'),
(669721, 'HP:0003113', 'Hypochloremia', 'MP:0013404', 'decreased circulating lactate level', 0.41818181818181815, 9.791230332350247, 2.023490672728489, 'UPHENO:0079822', 'decreased role blood level'),
(669722, 'HP:0003113', 'Hypochloremia', 'MP:0008822', 'decreased blood uric acid level', 0.40350877192982454, 9.791230332350247, 1.9876738482680443, 'UPHENO:0079822', 'decreased role blood level'),
(669723, 'HP:0003113', 'Hypochloremia', 'MP:0003020', 'decreased circulating chloride level', 0.5882352941176471, 16.607147267911277, 3.125525581017514, 'UPHENO:0034156', 'decreased level of chloride in blood'),
(669724, 'HP:0034920', 'Nasal mucosa vasculitis', 'MP:0031101', 'nasal obstruction', 0.4067796610169492, 10.26729726502665, 2.043655475129747, 'UPHENO:0075930', 'abnormal upper respiratory tract'),
(669725, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0003677', 'abnormal ear lobe morphology', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(669726, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0003330', 'abnormal auditory tube morphology', 0.4473684210526316, 9.948935785159481, 2.109701327999018, 'UPHENO:0003017', 'abnormal middle ear'),
(669727, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0000020', 'scaly ears', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(669728, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0003938', 'abnormal ear development', 0.45714285714285713, 7.8051695233081215, 1.888935545848356, 'UPHENO:0076730', 'abnormal ear morphology'),
(669729, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0030161', 'absent auditory bulla', 0.4444444444444444, 7.8051695233081215, 1.862515565728616, 'UPHENO:0076730', 'abnormal ear morphology'),
(669730, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0000035', 'abnormal membranous labyrinth morphology', 0.4358974358974359, 7.8051695233081215, 1.8445198242238607, 'UPHENO:0076730', 'abnormal ear morphology'),
(669731, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0030160', 'abnormal auditory bulla morphology', 0.45714285714285713, 7.8051695233081215, 1.888935545848356, 'UPHENO:0076730', 'abnormal ear morphology'),
(669732, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0030092', 'abnormal outer ear helix morphology', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(669733, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0002102', 'abnormal ear morphology', 0.47058823529411764, 7.8051695233081215, 1.9165127059701426, 'UPHENO:0076730', 'abnormal ear morphology'),
(669734, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0000026', 'abnormal inner ear morphology', 0.4722222222222222, 7.8051695233081215, 1.9198371017140292, 'UPHENO:0076730', 'abnormal ear morphology'),
(669735, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0002729', 'abnormal inner ear canal morphology', 0.4473684210526316, 7.8051695233081215, 1.8686322178776849, 'UPHENO:0076730', 'abnormal ear morphology'),
(669736, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0030413', 'tympanic membrane retraction', 0.425, 9.948935785159481, 2.056282497297679, 'UPHENO:0003017', 'abnormal middle ear'),
(669737, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0011238', 'abnormal inner ear development', 0.4473684210526316, 7.8051695233081215, 1.8686322178776849, 'UPHENO:0076730', 'abnormal ear morphology'),
(669738, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0030226', 'middle ear polyps', 0.4594594594594595, 9.948935785159481, 2.138020733773704, 'UPHENO:0003017', 'abnormal middle ear'),
(669739, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0030321', 'abnormal tegmen tympani morphology', 0.4358974358974359, 9.948935785159481, 2.0824782348584727, 'UPHENO:0003017', 'abnormal middle ear'),
(669740, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0002859', 'abnormal inner ear canal fusion', 0.4358974358974359, 7.8051695233081215, 1.8445198242238607, 'UPHENO:0076730', 'abnormal ear morphology'),
(669741, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0006287', 'inner ear cyst', 0.4146341463414634, 7.8051695233081215, 1.7989690943279903, 'UPHENO:0076730', 'abnormal ear morphology'),
(669742, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0004427', 'abnormal vestibular labyrinth morphology', 0.4146341463414634, 7.8051695233081215, 1.7989690943279903, 'UPHENO:0076730', 'abnormal ear morphology'),
(669743, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0012176', 'abnormal head development', 0.42424242424242425, 4.6730878730104815, 1.4080206418742023, 'UPHENO:0087907', 'abnormal head morphology'),
(669744, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0006018', 'abnormal tympanic membrane morphology', 0.4358974358974359, 9.948935785159481, 2.0824782348584727, 'UPHENO:0003017', 'abnormal middle ear'),
(669745, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0020900', 'abnormal middle ear epithelium morphology', 0.4473684210526316, 9.948935785159481, 2.109701327999018, 'UPHENO:0003017', 'abnormal middle ear'),
(669746, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0030227', 'abnormal tubotympanic recess morphology', 0.4594594594594595, 9.948935785159481, 2.138020733773704, 'UPHENO:0003017', 'abnormal middle ear'),
(669747, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0030187', 'abnormal epitympanic recess morphology', 0.4358974358974359, 9.948935785159481, 2.0824782348584727, 'UPHENO:0003017', 'abnormal middle ear'),
(669748, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0020290', 'floppy ears', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(669749, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0030324', 'abnormal anterior head development', 0.4117647058823529, 4.6730878730104815, 1.3871599235821914, 'UPHENO:0087907', 'abnormal head morphology'),
(669750, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0000432', 'abnormal head morphology', 0.4375, 4.6730878730104815, 1.4298517211382744, 'UPHENO:0087907', 'abnormal head morphology'),
(669751, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0003737', 'ossification of pinnae', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(669752, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0020304', 'abnormal horn morphology', 0.4117647058823529, 4.6730878730104815, 1.3871599235821914, 'UPHENO:0087907', 'abnormal head morphology'),
(669753, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0030228', 'absent tubotympanic recess', 0.4473684210526316, 9.948935785159481, 2.109701327999018, 'UPHENO:0003017', 'abnormal middle ear'),
(669754, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0002177', 'abnormal outer ear morphology', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(669755, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0000049', 'abnormal middle ear morphology', 0.4722222222222222, 9.948935785159481, 2.1675120680665656, 'UPHENO:0003017', 'abnormal middle ear'),
(669756, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0004426', 'abnormal cochlear labyrinth morphology', 0.4146341463414634, 7.8051695233081215, 1.7989690943279903, 'UPHENO:0076730', 'abnormal ear morphology'),
(669757, 'HP:0040100', 'Abnormality of the vestibular window', 'MP:0030154', 'abnormal tympanic cavity morphology', 0.4473684210526316, 9.948935785159481, 2.109701327999018, 'UPHENO:0003017', 'abnormal middle ear'),
(669758, 'HP:0007760', 'Crystalline corneal dystrophy', 'MP:0012353', 'bilateral cornea degeneration', 0.43333333333333335, 11.115294171581601, 2.1946816339396533, 'UPHENO:0020998', 'abnormal cornea morphology'),
(669759, 'HP:0007760', 'Crystalline corneal dystrophy', 'MP:0009742', 'increased corneal stroma thickness', 0.40625, 12.87018167374507, 2.2865938215955484, 'UPHENO:0088026', 'abnormal substantia propria of cornea morphology'),
(669760, 'HP:0007760', 'Crystalline corneal dystrophy', 'MP:0031499', 'decreased cornea size', 0.41935483870967744, 11.115294171581601, 2.158993375287247, 'UPHENO:0020998', 'abnormal cornea morphology'),
(669761, 'HP:0007760', 'Crystalline corneal dystrophy', 'MP:0020859', 'disorganized corneal epithelium', 0.4098360655737705, 10.417322709031257, 2.0662513285855773, 'UPHENO:0087577', 'abnormal cornea morphology'),
(669762, 'HP:0007760', 'Crystalline corneal dystrophy', 'MP:0031432', 'cornea perforation', 0.4482758620689655, 11.115294171581601, 2.2322002770620495, 'UPHENO:0020998', 'abnormal cornea morphology'),
(669763, 'HP:0007760', 'Crystalline corneal dystrophy', 'MP:0005300', 'abnormal corneal stroma morphology', 0.4107142857142857, 12.87018167374507, 2.2991231966002377, 'UPHENO:0088026', 'abnormal substantia propria of cornea morphology'),
(669764, 'HP:0007760', 'Crystalline corneal dystrophy', 'MP:0012351', 'cornea degeneration', 0.4406779661016949, 11.115294171581601, 2.213202482411992, 'UPHENO:0020998', 'abnormal cornea morphology'),
(669765, 'HP:0007760', 'Crystalline corneal dystrophy', 'MP:0031500', 'increased cornea size', 0.41935483870967744, 11.115294171581601, 2.158993375287247, 'UPHENO:0020998', 'abnormal cornea morphology'),
(669766, 'HP:0007760', 'Crystalline corneal dystrophy', 'MP:0020853', 'abnormal corneal epithelium thickness', 0.4032258064516129, 10.417322709031257, 2.049520273238552, 'UPHENO:0087577', 'abnormal cornea morphology'),
(669767, 'HP:0007760', 'Crystalline corneal dystrophy', 'MP:0011961', 'abnormal cornea thickness', 0.4262295081967213, 11.115294171581601, 2.1766181034382464, 'UPHENO:0020998', 'abnormal cornea morphology'),
(669768, 'HP:0007760', 'Crystalline corneal dystrophy', 'MP:0031176', 'abnormal Descemet membrane thickness', 0.4032258064516129, 10.417322709031257, 2.049520273238552, 'UPHENO:0087577', 'abnormal cornea morphology'),
(669769, 'HP:0007760', 'Crystalline corneal dystrophy', 'MP:0031498', 'abnormal cornea size', 0.4482758620689655, 11.115294171581601, 2.2322002770620495, 'UPHENO:0020998', 'abnormal cornea morphology'),
(669770, 'HP:0007760', 'Crystalline corneal dystrophy', 'MP:0012352', 'progressive cornea degeneration', 0.43333333333333335, 11.115294171581601, 2.1946816339396533, 'UPHENO:0020998', 'abnormal cornea morphology'),
(669771, 'HP:0012701', 'Bowel urgency', 'MP:0001664', 'abnormal digestion', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669772, 'HP:0012701', 'Bowel urgency', 'MP:0008006', 'increased stomach pH', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669773, 'HP:0012701', 'Bowel urgency', 'MP:0010155', 'abnormal intestine physiology', 0.5, 9.977790647831666, 2.233583516216896, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669774, 'HP:0012701', 'Bowel urgency', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669775, 'HP:0012701', 'Bowel urgency', 'MP:0005037', 'mucous diarrhea', 0.4375, 9.977790647831666, 2.0893260656073656, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669776, 'HP:0012701', 'Bowel urgency', 'MP:0014204', 'abnormal intestinal epithelial sodium ion transmembrane transport', 0.4411764705882353, 9.977790647831666, 2.098086381033602, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669777, 'HP:0012701', 'Bowel urgency', 'MP:0014207', 'increased intestinal epithelial chloride transmembrane transport', 0.42857142857142855, 9.977790647831666, 2.067896513834253, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669778, 'HP:0012701', 'Bowel urgency', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669779, 'HP:0012701', 'Bowel urgency', 'MP:0006001', 'abnormal intestinal transit time', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669780, 'HP:0012701', 'Bowel urgency', 'MP:0010377', 'abnormal gut flora balance', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669781, 'HP:0012701', 'Bowel urgency', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4482758620689655, 5.110459900932426, 1.5135705525872798, 'UPHENO:0002833', 'abnormal digestive system'),
(669782, 'HP:0012701', 'Bowel urgency', 'MP:0013799', 'abnormal intestinal goblet cell physiology', 0.40540540540540543, 9.977790647831666, 2.0112310316406865, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669783, 'HP:0012701', 'Bowel urgency', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669784, 'HP:0012701', 'Bowel urgency', 'MP:0008002', 'hyperchlorhydria', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669785, 'HP:0012701', 'Bowel urgency', 'MP:0003261', 'hematemesis', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669786, 'HP:0012701', 'Bowel urgency', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669787, 'HP:0012701', 'Bowel urgency', 'MP:0001671', 'abnormal vitamin absorption', 0.4117647058823529, 9.977790647831666, 2.026944012907139, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669788, 'HP:0012701', 'Bowel urgency', 'MP:0001666', 'abnormal intestinal absorption', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669789, 'HP:0012701', 'Bowel urgency', 'MP:0003868', 'abnormal feces composition', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669790, 'HP:0012701', 'Bowel urgency', 'MP:0001983', 'abnormal olfactory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669791, 'HP:0012701', 'Bowel urgency', 'MP:0011220', 'increased intestinal calcium absorption', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669792, 'HP:0012701', 'Bowel urgency', 'MP:0014206', 'decreased intestinal epithelial sodium ion transmembrane transport', 0.42857142857142855, 9.977790647831666, 2.067896513834253, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669793, 'HP:0012701', 'Bowel urgency', 'MP:0020147', 'abnormal defecation amount', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669794, 'HP:0012701', 'Bowel urgency', 'MP:0005342', 'abnormal intestinal lipid absorption', 0.4117647058823529, 9.977790647831666, 2.026944012907139, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669795, 'HP:0012701', 'Bowel urgency', 'MP:0014201', 'abnormal intestinal epithelium physiology', 0.46875, 9.977790647831666, 2.1626579401678607, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669796, 'HP:0012701', 'Bowel urgency', 'MP:0010994', 'aerophagia', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669797, 'HP:0012701', 'Bowel urgency', 'MP:0003259', 'nausea', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669798, 'HP:0012701', 'Bowel urgency', 'MP:0008001', 'hypochlorhydria', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669799, 'HP:0012701', 'Bowel urgency', 'MP:0001665', 'chronic diarrhea', 0.4375, 9.977790647831666, 2.0893260656073656, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669800, 'HP:0012701', 'Bowel urgency', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669801, 'HP:0012701', 'Bowel urgency', 'MP:0000505', 'decreased digestive secretion', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669802, 'HP:0012701', 'Bowel urgency', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669803, 'HP:0012701', 'Bowel urgency', 'MP:0002164', 'abnormal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669804, 'HP:0012701', 'Bowel urgency', 'MP:0006002', 'abnormal small intestinal transit time', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669805, 'HP:0012701', 'Bowel urgency', 'MP:0006003', 'abnormal large intestinal transit time', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669806, 'HP:0012701', 'Bowel urgency', 'MP:0008004', 'abnormal stomach pH', 0.4827586206896552, 9.977790647831666, 2.194735622045935, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669807, 'HP:0012701', 'Bowel urgency', 'MP:0008003', 'achlorhydria', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669808, 'HP:0012701', 'Bowel urgency', 'MP:0014203', 'abnormal intestinal epithelial chloride transmembrane transport', 0.4411764705882353, 9.977790647831666, 2.098086381033602, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669809, 'HP:0012701', 'Bowel urgency', 'MP:0009247', 'meteorism', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669810, 'HP:0012701', 'Bowel urgency', 'MP:0001858', 'intestinal inflammation', 0.40540540540540543, 9.977790647831666, 2.0112310316406865, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669811, 'HP:0012701', 'Bowel urgency', 'MP:0014202', 'abnormal intestinal epithelial transmembrane transport', 0.45454545454545453, 9.977790647831666, 2.129638322668436, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669812, 'HP:0012701', 'Bowel urgency', 'MP:0014205', 'increased intestinal epithelial sodium ion transmembrane transport', 0.42857142857142855, 9.977790647831666, 2.067896513834253, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669813, 'HP:0012701', 'Bowel urgency', 'MP:0001985', 'abnormal gustatory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669814, 'HP:0012701', 'Bowel urgency', 'MP:0010154', 'abnormal gastroesophageal sphincter physiology', 0.4411764705882353, 9.977790647831666, 2.098086381033602, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669815, 'HP:0012701', 'Bowel urgency', 'MP:0020444', 'abnormal intestine apoptosis', 0.40540540540540543, 9.977790647831666, 2.0112310316406865, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669816, 'HP:0012701', 'Bowel urgency', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.4375, 9.977790647831666, 2.0893260656073656, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669817, 'HP:0012701', 'Bowel urgency', 'MP:0008005', 'decreased stomach pH', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669818, 'HP:0012701', 'Bowel urgency', 'MP:0000501', 'abnormal digestive secretion', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669819, 'HP:0012701', 'Bowel urgency', 'MP:0010680', 'abnormal skin adnexa physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669820, 'HP:0012701', 'Bowel urgency', 'MP:0014208', 'decreased intestinal epithelial chloride transmembrane transport', 0.42857142857142855, 9.977790647831666, 2.067896513834253, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669821, 'HP:0012701', 'Bowel urgency', 'MP:0000503', 'excessive digestive secretion', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669822, 'HP:0012701', 'Bowel urgency', 'MP:0003286', 'gastroesophageal reflux', 0.42857142857142855, 9.977790647831666, 2.067896513834253, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669823, 'HP:0012701', 'Bowel urgency', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.4166666666666667, 9.977790647831666, 2.0389734598395, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669824, 'HP:0012701', 'Bowel urgency', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669825, 'HP:0012701', 'Bowel urgency', 'MP:0001663', 'abnormal digestive system physiology', 0.5, 9.977790647831666, 2.233583516216896, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669826, 'HP:0012701', 'Bowel urgency', 'MP:0003292', 'melena', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669827, 'HP:0012701', 'Bowel urgency', 'MP:0003866', 'abnormal defecation', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669828, 'HP:0012701', 'Bowel urgency', 'MP:0003260', 'vomiting', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669829, 'HP:0012701', 'Bowel urgency', 'MP:0005036', 'diarrhea', 0.45161290322580644, 9.977790647831666, 2.1227574054155505, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669830, 'HP:0012701', 'Bowel urgency', 'MP:0011221', 'decreased intestinal calcium absorption', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669831, 'HP:0500061', 'Retinopathy of prematurity zone III', 'MP:0001325', 'abnormal retina morphology', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(669832, 'HP:0500061', 'Retinopathy of prematurity zone III', 'MP:0020443', 'tractional retina detachment', 0.4153846153846154, 9.356059413574362, 1.9713860963857883, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(669833, 'HP:0500061', 'Retinopathy of prematurity zone III', 'MP:0006188', 'calcified retina', 0.4307692307692308, 9.356059413574362, 2.0075613357047524, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(669834, 'HP:0500061', 'Retinopathy of prematurity zone III', 'MP:0001326', 'retina degeneration', 0.42857142857142855, 9.356059413574362, 2.0024334567407545, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(669835, 'HP:0500061', 'Retinopathy of prematurity zone III', 'MP:0006186', 'retina fibrosis', 0.43548387096774194, 9.356059413574362, 2.01851751798877, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(669836, 'HP:0500061', 'Retinopathy of prematurity zone III', 'MP:0001329', 'retina hyperplasia', 0.4153846153846154, 9.356059413574362, 1.9713860963857883, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(669837, 'HP:0500061', 'Retinopathy of prematurity zone III', 'MP:0003099', 'retina detachment', 0.421875, 9.356059413574362, 1.9867278538092943, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(669838, 'HP:0500061', 'Retinopathy of prematurity zone III', 'MP:0020442', 'serous retina detachment', 0.4153846153846154, 9.356059413574362, 1.9713860963857883, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(669839, 'HP:0500061', 'Retinopathy of prematurity zone III', 'MP:0020441', 'rhegmatogenous retina detachment', 0.4153846153846154, 9.356059413574362, 1.9713860963857883, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(669840, 'HP:0500061', 'Retinopathy of prematurity zone III', 'MP:0020038', 'retina macular degeneration', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(669841, 'HP:0100259', 'Postaxial polydactyly', 'MP:0009743', 'preaxial polydactyly', 0.46938775510204084, 11.371930806217245, 2.310377690401735, 'UPHENO:0056010', 'abnormally increased number of digit in the independent continuant'),
(669842, 'HP:0100259', 'Postaxial polydactyly', 'MP:0009744', 'postaxial polydactyly', 0.46938775510204084, 11.371930806217245, 2.310377690401735, 'UPHENO:0056010', 'abnormally increased number of digit in the independent continuant'),
(669843, 'HP:0100259', 'Postaxial polydactyly', 'MP:0000413', 'polyphalangy', 0.4032258064516129, 10.47786425096631, 2.0554671640496753, 'UPHENO:0056112', 'abnormally increased number of anatomical entity in the limb'),
(669844, 'HP:0100259', 'Postaxial polydactyly', 'MP:0000562', 'polydactyly', 0.4791666666666667, 11.371930806217245, 2.334320067595508, 'UPHENO:0056010', 'abnormally increased number of digit in the independent continuant'),
(669845, 'HP:0002919', 'Ketonuria', 'MP:0030766', 'increased urine catecholamine level', 0.4074074074074074, 9.50911518495075, 1.9682692814346299, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(669846, 'HP:0002919', 'Ketonuria', 'MP:0030612', 'organic aciduria', 0.5, 9.50911518495075, 2.180494804505476, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(669847, 'HP:0002919', 'Ketonuria', 'MP:0006272', 'abnormal urine organic anion level', 0.4090909090909091, 8.94655706237675, 1.9131009283049856, 'UPHENO:0051686', 'abnormal urine chemical entity level'),
(669848, 'HP:0002919', 'Ketonuria', 'MP:0011770', 'increased urine selenium level', 0.4117647058823529, 9.50911518495075, 1.9787667920532377, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(669849, 'HP:0002919', 'Ketonuria', 'MP:0011473', 'increased urine glycosaminoglycan level', 0.44, 9.50911518495075, 2.0454854390531185, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(669850, 'HP:0002919', 'Ketonuria', 'MP:0011741', 'increased urine nitrite level', 0.40384615384615385, 9.50911518495075, 1.9596478239526658, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(669851, 'HP:0002919', 'Ketonuria', 'MP:0011477', 'abnormal urine nucleoside level', 0.4090909090909091, 8.94655706237675, 1.9131009283049856, 'UPHENO:0051686', 'abnormal urine chemical entity level'),
(669852, 'HP:0002919', 'Ketonuria', 'MP:0001759', 'increased urine glucose level', 0.4074074074074074, 9.50911518495075, 1.9682692814346299, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(669853, 'HP:0002919', 'Ketonuria', 'MP:0030778', 'increased urine citrate level', 0.4074074074074074, 9.50911518495075, 1.9682692814346299, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(669854, 'HP:0002919', 'Ketonuria', 'MP:0009810', 'increased urine uric acid level', 0.41509433962264153, 9.50911518495075, 1.9867510886099355, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(669855, 'HP:0000476', 'Cystic hygroma', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(669856, 'HP:0000476', 'Cystic hygroma', 'MP:0003385', 'abnormal body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(669857, 'HP:0000476', 'Cystic hygroma', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(669858, 'HP:0000476', 'Cystic hygroma', 'MP:0005499', 'abnormal olfactory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(669859, 'HP:0000476', 'Cystic hygroma', 'MP:0010678', 'abnormal skin adnexa morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(669860, 'HP:0000476', 'Cystic hygroma', 'MP:0005500', 'abnormal gustatory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(669861, 'HP:0000476', 'Cystic hygroma', 'MP:0002111', 'abnormal tail morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(669862, 'HP:0000476', 'Cystic hygroma', 'MP:0002163', 'abnormal gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(669863, 'HP:0000476', 'Cystic hygroma', 'MP:0014134', 'abnormal embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(669864, 'HP:0000476', 'Cystic hygroma', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(669865, 'HP:0000476', 'Cystic hygroma', 'MP:0000428', 'abnormal craniofacial morphology', 0.45454545454545453, 3.8548363184545034, 1.3237062841016616, 'UPHENO:0002764', 'abnormal craniocervical region'),
(669866, 'HP:0000476', 'Cystic hygroma', 'MP:0012723', 'abnormal nuchal region morphology', 0.4074074074074074, 10.533898285880637, 2.0716148750537497, 'UPHENO:0003074', 'abnormal neck'),
(669867, 'HP:0000476', 'Cystic hygroma', 'MP:0012719', 'abnormal neck morphology', 0.44, 10.533898285880637, 2.1528853303851276, 'UPHENO:0003074', 'abnormal neck'),
(669868, 'HP:0000476', 'Cystic hygroma', 'MP:0003935', 'abnormal craniofacial development', 0.43478260869565216, 3.8548363184545034, 1.294610285233511, 'UPHENO:0002764', 'abnormal craniocervical region'),
(669869, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0001038', 'abnormal cholinergic neuron morphology', 0.43902439024390244, 9.126020578174659, 2.001635736013532, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669870, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0010385', 'abnormal glycinergic neuron morphology', 0.43902439024390244, 9.126020578174659, 2.001635736013532, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669871, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0001106', 'abnormal Schwann cell morphology', 0.4318181818181818, 7.61846258113911, 1.8137780073750325, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(669872, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0009538', 'abnormal synapse morphology', 0.4090909090909091, 9.126020578174659, 1.9321935862402129, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669873, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0001026', 'abnormal adrenergic neuron morphology', 0.43902439024390244, 9.126020578174659, 2.001635736013532, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669874, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0003243', 'abnormal dopaminergic neuron morphology', 0.43902439024390244, 9.126020578174659, 2.001635736013532, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669875, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0002883', 'chromatolysis', 0.45, 9.126020578174659, 2.026501729626352, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669876, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0003877', 'abnormal serotonergic neuron morphology', 0.43902439024390244, 9.126020578174659, 2.001635736013532, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669877, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0008946', 'abnormal neuron number', 0.4090909090909091, 9.126020578174659, 1.9321935862402129, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669878, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0003245', 'abnormal GABAergic neuron morphology', 0.43902439024390244, 9.126020578174659, 2.001635736013532, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669879, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0020581', 'abnormal neuron polarity', 0.45, 9.126020578174659, 2.026501729626352, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669880, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0000965', 'abnormal sensory neuron morphology', 0.43478260869565216, 9.126020578174659, 1.991942527782612, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669881, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0003247', 'abnormal glutaminergic neuron morphology', 0.43902439024390244, 9.126020578174659, 2.001635736013532, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669882, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0008415', 'abnormal neurite morphology', 0.4186046511627907, 9.126020578174659, 1.954531826456467, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669883, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0001032', 'abnormal peptidergic neuron morphology', 0.43902439024390244, 9.126020578174659, 2.001635736013532, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669884, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0000969', 'abnormal nociceptor morphology', 0.4166666666666667, 9.126020578174659, 1.9500021985216942, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669885, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0001001', 'abnormal chemoreceptor morphology', 0.4166666666666667, 9.126020578174659, 1.9500021985216942, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669886, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0012203', 'abnormal neuronal stem cell morphology', 0.4146341463414634, 6.121988824155609, 1.5932311853638002, 'UPHENO:0084928', 'abnormal cell morphology'),
(669887, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0002882', 'abnormal neuron morphology', 0.46153846153846156, 9.126020578174659, 2.0523180790557474, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669888, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0000971', 'abnormal thermoreceptor morphology', 0.4166666666666667, 9.126020578174659, 1.9500021985216942, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669889, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0000958', 'peripheral nervous system degeneration', 0.40476190476190477, 7.61846258113911, 1.756036282569117, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(669890, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0001046', 'abnormal enteric neuron morphology', 0.425531914893617, 9.126020578174659, 1.9706377170827765, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669891, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0004074', 'abnormal Schwann cell precursor morphology', 0.41304347826086957, 7.61846258113911, 1.7739098859620746, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(669892, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0011975', 'neuronal cytoplasmic inclusions', 0.45, 9.126020578174659, 2.026501729626352, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669893, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0004191', 'neuronal intranuclear inclusions', 0.45, 9.126020578174659, 2.026501729626352, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669894, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0004101', 'abnormal brain interneuron morphology', 0.4186046511627907, 9.126020578174659, 1.954531826456467, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669895, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0000968', 'abnormal sensory neuron innervation pattern', 0.40816326530612246, 9.126020578174659, 1.9300016472631925, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669896, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0000937', 'abnormal motor neuron morphology', 0.4222222222222222, 13.87018167374507, 2.419979117454236, 'UPHENO:0084964', 'abnormal motor neuron morphology'),
(669897, 'HP:0006802', 'Abnormal anterior horn cell morphology', 'MP:0021020', 'neurite dystrophy', 0.4090909090909091, 9.126020578174659, 1.9321935862402129, 'UPHENO:0084885', 'abnormal neuron morphology'),
(669898, 'HP:0011840', 'Abnormality of T cell physiology', 'MP:0002442', 'abnormal leukocyte physiology', 0.4090909090909091, 9.343486828203092, 1.955079415427552, 'UPHENO:0085616', 'abnormality of leukocyte physiology'),
(669899, 'HP:0011840', 'Abnormality of T cell physiology', 'MP:0008042', 'abnormal NK T cell physiology', 0.4166666666666667, 11.592196926445306, 2.197744765136649, 'UPHENO:0085622', 'abnormality of T cell physiology'),
(669900, 'HP:0011840', 'Abnormality of T cell physiology', 'MP:0003945', 'abnormal lymphocyte physiology', 0.4222222222222222, 9.680357114865052, 2.0216977748771012, 'UPHENO:0085566', 'abnormality of lymphocyte physiology'),
(669901, 'HP:0011840', 'Abnormality of T cell physiology', 'MP:0020192', 'decreased lymphocyte activation involved in immune response', 0.40425531914893614, 9.680357114865052, 1.9782153206730166, 'UPHENO:0085566', 'abnormality of lymphocyte physiology'),
(669902, 'HP:0011840', 'Abnormality of T cell physiology', 'MP:0001828', 'abnormal T cell activation', 0.425531914893617, 11.592196926445306, 2.2210019711684574, 'UPHENO:0085622', 'abnormality of T cell physiology'),
(669903, 'HP:0011840', 'Abnormality of T cell physiology', 'MP:0005621', 'abnormal cell physiology', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(669904, 'HP:0011840', 'Abnormality of T cell physiology', 'MP:0005463', 'abnormal CD4-positive, alpha-beta T cell physiology', 0.4166666666666667, 11.592196926445306, 2.197744765136649, 'UPHENO:0085622', 'abnormality of T cell physiology'),
(669905, 'HP:0011840', 'Abnormality of T cell physiology', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.41025641025641024, 7.733703155395898, 1.7812358896343274, 'UPHENO:0085578', 'abnormality of cell physiology'),
(669906, 'HP:0011840', 'Abnormality of T cell physiology', 'MP:0020191', 'abnormal lymphocyte activation involved in immune response', 0.41304347826086957, 9.680357114865052, 1.9996020537925083, 'UPHENO:0085566', 'abnormality of lymphocyte physiology'),
(669907, 'HP:0011840', 'Abnormality of T cell physiology', 'MP:0002444', 'abnormal T cell physiology', 0.43478260869565216, 11.592196926445306, 2.245013501116109, 'UPHENO:0085622', 'abnormality of T cell physiology'),
(669908, 'HP:0011840', 'Abnormality of T cell physiology', 'MP:0004946', 'abnormal regulatory T cell physiology', 0.4166666666666667, 11.592196926445306, 2.197744765136649, 'UPHENO:0085622', 'abnormality of T cell physiology'),
(669909, 'HP:0011840', 'Abnormality of T cell physiology', 'MP:0020193', 'increased lymphocyte activation involved in immune response', 0.40425531914893614, 9.680357114865052, 1.9782153206730166, 'UPHENO:0085566', 'abnormality of lymphocyte physiology'),
(669910, 'HP:0011840', 'Abnormality of T cell physiology', 'MP:0006412', 'abnormal T cell apoptosis', 0.40816326530612246, 11.592196926445306, 2.1752031973058314, 'UPHENO:0085622', 'abnormality of T cell physiology'),
(669911, 'HP:0011840', 'Abnormality of T cell physiology', 'MP:0008051', 'abnormal memory T cell physiology', 0.4166666666666667, 11.592196926445306, 2.197744765136649, 'UPHENO:0085622', 'abnormality of T cell physiology'),
(669912, 'HP:0011840', 'Abnormality of T cell physiology', 'MP:0001819', 'abnormal immune cell physiology', 0.43243243243243246, 7.733703155395898, 1.8287438495312094, 'UPHENO:0085578', 'abnormality of cell physiology'),
(669913, 'HP:0011840', 'Abnormality of T cell physiology', 'MP:0004392', 'abnormal CD8-positive, alpha-beta T cell physiology', 0.4166666666666667, 11.592196926445306, 2.197744765136649, 'UPHENO:0085622', 'abnormality of T cell physiology'),
(669914, 'HP:0011840', 'Abnormality of T cell physiology', 'MP:0001790', 'abnormal immune system physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(669915, 'HP:0011840', 'Abnormality of T cell physiology', 'MP:0005094', 'abnormal T cell proliferation', 0.40816326530612246, 11.592196926445306, 2.1752031973058314, 'UPHENO:0085622', 'abnormality of T cell physiology'),
(669916, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0005402', 'abnormal action potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669917, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0001636', 'irregular heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669918, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669919, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669920, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669921, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669922, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0020154', 'impaired humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669923, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669924, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669925, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0003880', 'abnormal central pattern generator function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669926, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0014207', 'increased intestinal epithelial chloride transmembrane transport', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669927, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0003256', 'biliary cirrhosis', 0.4666666666666667, 12.637520916954795, 2.4284788986617882, 'UPHENO:0002242', 'abnormality of hepatobiliary system physiology'),
(669928, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0014048', 'abnormal Peyers patch physiology', 0.40625, 5.110459900932426, 1.4408762385277225, 'UPHENO:0002833', 'abnormal digestive system'),
(669929, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0031154', 'intestinal hemorrhage', 0.4117647058823529, 9.977790647831666, 2.026944012907139, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669930, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669931, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0005532', 'abnormal vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669932, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0002723', 'abnormal immune serum protein physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669933, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0006002', 'abnormal small intestinal transit time', 0.5, 9.977790647831666, 2.233583516216896, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669934, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0014201', 'abnormal intestinal epithelium physiology', 0.4666666666666667, 9.977790647831666, 2.1578466818385045, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669935, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669936, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0009247', 'meteorism', 0.5, 9.977790647831666, 2.233583516216896, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669937, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0020096', 'high mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669938, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669939, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669940, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669941, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.5, 9.977790647831666, 2.233583516216896, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669942, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669943, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0020371', 'abnormal glymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669944, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669945, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669946, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669947, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0003303', 'peritoneal inflammation', 0.4375, 9.977790647831666, 2.0893260656073656, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669948, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669949, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669950, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0003889', 'enhanced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669951, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669952, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669953, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0001845', 'abnormal inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669954, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669955, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0005414', 'extrahepatic cholestasis', 0.45161290322580644, 12.637520916954795, 2.388988805097841, 'UPHENO:0002242', 'abnormality of hepatobiliary system physiology'),
(669956, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0008005', 'decreased stomach pH', 0.5185185185185185, 9.977790647831666, 2.2745701186821226, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669957, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669958, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669959, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669960, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0008001', 'hypochlorhydria', 0.5, 9.977790647831666, 2.233583516216896, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669961, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0000465', 'gastrointestinal hemorrhage', 0.42424242424242425, 9.977790647831666, 2.0574260844607504, 'UPHENO:0002443', 'abnormality of digestive system physiology'),
(669962, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669963, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669964, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669965, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669966, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669967, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669968, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0004072', 'abnormal frontal plane axis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669969, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669970, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.41935483870967744, 5.110459900932426, 1.4639317222766202, 'UPHENO:0002833', 'abnormal digestive system'),
(669971, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669972, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(669973, 'HP:0025155', 'Abnormality of hepatobiliary system physiology', 'MP:0005671', 'abnormal response to transplant', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
